PTI-801 represents a new class of drugs to treat pain. PTI-801 can minimize the opioid tolerance, dependence or addiction that is often associated with repeat use of oxycodone. It is... It is a combination of oxycodone with ultralow-dose naltrexone, an opioid antagonist.
- Mechanism
- Curator reviewed
PTI-801 is a novel form of oxycodone that minimizes the abuse and drug dependence that is often associated with oxycodone and other narcotic painkillers. The goal of developing PTI-801 is to ensure the safety of patients who have a legitimate medical need to treat severe chronic pain with a narcotic painkiller, and to protect the public from the consequences of abuse.
- Primary indication
- Investigated for use/treatment in addictions, osteoarthritis, and pain (acute or chronic).Curator reviewed
- Code names
- PTI-801
Resolves to
What you can answer from here — as of April 23, 2025
Which companies are running trials of PTI-801, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account